Review of the literature on reference pricing

Author： Lopez-Casasnovas G.   Puig-Junoy J.  

Publisher： Elsevier

ISSN： 0168-8510

Source： Health Policy, Vol.54, Iss.2, 2000-11, pp. : 87-123

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The German experience in reference pricing

By Giuliani G.   Selke G.   Garattini L.  

Health Policy, Vol. 44, Iss. 1, 1998-04 ,pp. : 73-85

Elsevier

Access to resources Recommend Favorite

What is Required to Evaluate the Impact of Pharmaceutical Reference Pricing?

By Puig-Junoy Jaume  

Applied Health Economics and Health Policy, Vol. 4, Iss. 2, 2005-01 ,pp. : 87-98

Adis International

Access to resources Recommend Favorite

Impact of Cross-Reference Pricing on Pharmaceutical Prices: Manufacturers' Pricing Strategies and Price Regulation

By Stargardt Tom   Schreyögg Jonas  

Applied Health Economics and Health Policy, Vol. 5, Iss. 4, 2006-01 ,pp. : 235-247

Adis International

Access to resources Recommend Favorite

Vaccination and HIV: a review of the literature

By Rousseau M.C.   Moreau J.   Delmont J.  

Vaccine, Vol. 18, Iss. 9, 1999-12 ,pp. : 825-831

Elsevier

Access to resources Recommend Favorite

What is Germany's experience on reference based drug pricing and the etiology of adverse health outcomes or substitution?

By Schneeweiss S.   Schoffski O.   Selke G.W.  

Health Policy, Vol. 44, Iss. 3, 1998-06 ,pp. : 253-260

Elsevier

Access to resources Recommend Favorite